Skip to main content
. 2018 Feb 13;15(4):5799–5802. doi: 10.3892/ol.2018.8040

Figure 2.

Figure 2.

Pathological results of the patient at different times in the study period. (A) June 26, 2009: Predominant papillary/micropapillary adenocarcinoma, partly combined with acinar adenocarcinoma. (B) Jan 30, 2013: Predominant papillary adenocarcinoma and acinar adenocarcinoma. (C) Sep 20, 2015: Neuroendocrine carcinoma (inclining toward small cell lung cancer). (D) Mar 16, 2016: Small cell lung cancer.